29731

506879

GUJTHEM

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

GUJARAT THEMIS BIOSYN LTD Share Price Today

GUJARAT THEMIS BIOSYN LTD is currently trading at ₹413.2, up by ₹1.55 from the previous close. The stock touched an intraday high of ₹420.00 and a low of ₹401.55 during the latest trading session. Over the past one year, GUJARAT THEMIS BIOSYN LTD has delivered a return of 25.11%, while the stock has gained 7.95% in the last one month.

GUJARAT THEMIS BIOSYN LTD performance

Today’s low Today’s high
₹ 401.55 ₹ 420.00
₹ 413.20
52 week low 52 week high
₹ 225.05 ₹ 479.00
₹ 413.20
Open Price ₹ 415.85
Prev. Close ₹ 411.65
Volume (Shares) 137723.00
Total traded value ₹ 569.07
Upper Circuit ₹ 493.95
Lower Circuit ₹ 329.35
info

Investment Returns

Over 1 Month 7.95% Over 3 Months 37.36% Over 6 Months 9.50% Over 1 Year 25.11%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

GUJARAT THEMIS BIOSYN LTD fundamentals


  • Market cap (Cr) 4,502.40
  • P/E Ratio (TTM) 96.60
  • Beta 1.89
  • Book Value / share 26.40
  • Return on equity 21.69%
  • EPS (TTM) 4.28
  • Dividend yield 0.16%
  • Net profit/quarter (Cr) 10.89
info icon alternate text
  • Market cap (Cr) 4,505.20
  • P/E Ratio (TTM) 96.60
  • Beta 1.72
  • Book Value / share 26.40
  • Return on equity 21.69%
  • EPS (TTM) 4.28
  • Dividend yield 0.16%
  • Net profit/quarter (Cr) 10.89
info icon alternate text

GUJARAT THEMIS BIOSYN LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 44.23
Operating Expense 30.82
Net Profit 10.89
Net Profit Margin (%) 24.62
Earnings Per Share (EPS) 1.00
EBITDA 20.29
Effective Tax Rate (%) 24.05
Particulars DEC 2025 (Values in Cr)
Revenue 43.37
Operating Expense 26.91
Net Profit 12.46
Net Profit Margin (%) 28.72
Earnings Per Share (EPS) 1.14
EBITDA 21.72
Effective Tax Rate (%) 26.14
Particulars SEP 2025 (Values in Cr)
Revenue 42.35
Operating Expense 24.40
Net Profit 14.26
Net Profit Margin (%) 33.67
Earnings Per Share (EPS) 1.31
EBITDA 21.76
Effective Tax Rate (%) 23.98
Particulars JUN 2025 (Values in Cr)
Revenue 35.87
Operating Expense 24.02
Net Profit 9.06
Net Profit Margin (%) 25.25
Earnings Per Share (EPS) 0.83
EBITDA 14.18
Effective Tax Rate (%) 25.24
Particulars MAR 2025 (Values in Cr)
Revenue 37.74
Operating Expense 23.00
Net Profit 12.00
Net Profit Margin (%) 31.79
Earnings Per Share (EPS) 1.10
EBITDA 17.39
Effective Tax Rate (%) 25.41
Particulars MAR 2026 (Values in Cr)
Revenue 165.82
Operating Expense 106.16
Net Profit 46.68
Net Profit Margin (%) 28.15
Earnings Per Share (EPS) 4.28
EBITDA 77.96
Effective Tax Rate (%) 24.81
Particulars MAR 2025 (Values in Cr)
Revenue 150.80
Operating Expense 87.69
Net Profit 48.77
Net Profit Margin (%) 32.34
Earnings Per Share (EPS) 4.48
EBITDA 71.27
Effective Tax Rate (%) 25.58
Particulars MAR 2024 (Values in Cr)
Revenue 169.82
Operating Expense 94.85
Net Profit 59.16
Net Profit Margin (%) 34.83
Earnings Per Share (EPS) 8.14
EBITDA 83.10
Effective Tax Rate (%) 25.42
Particulars MAR 2023 (Values in Cr)
Revenue 148.39
Operating Expense 77.51
Net Profit 57.97
Net Profit Margin (%) 39.06
Earnings Per Share (EPS) 39.90
EBITDA 80.22
Effective Tax Rate (%) 25.17
Particulars MAR 2022 (Values in Cr)
Revenue 114.85
Operating Expense 59.87
Net Profit 43.62
Net Profit Margin (%) 37.97
Earnings Per Share (EPS) 30.03
EBITDA 62.08
Effective Tax Rate (%) 26.10
Particulars MAR 2025 (Values in Cr)
Book Value / Share 22.79
ROE % 21.69
ROCE % 27.21
Total Debt to Total Equity 0.07
EBITDA Margin 47.26
Particulars MAR 2024 (Values in Cr)
Book Value / Share 27.72
ROE % 33.76
ROCE % 44.82
Total Debt to Total Equity 0.01
EBITDA Margin 48.93
Particulars MAR 2023 (Values in Cr)
Book Value / Share 102.66
ROE % 45.92
ROCE % 60.85
Total Debt to Total Equity 0.01
EBITDA Margin 54.06
Particulars MAR 2022 (Values in Cr)
Book Value / Share 71.11
ROE % 50.35
ROCE % 66.38
Total Debt to Total Equity 0.03
EBITDA Margin 54.07
Particulars MAR 2021 (Values in Cr)
Book Value / Share 48.14
ROE % 53.83
ROCE % 66.39
Total Debt to Total Equity 0.12
EBITDA Margin 48.13
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 12.54
Total Assets 301.31
Total Liabilities 301.31
Total Equity 248.38
Share Outstanding 10
Price to Book Ratio 12.35
Return on Assets (%) 16.18
Return on Capital (%) 17.53
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 8.15
Total Assets 221.11
Total Liabilities 221.11
Total Equity 201.37
Share Outstanding 7
Price to Book Ratio 14.29
Return on Assets (%) 26.75
Return on Capital (%) 29.38
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 9.33
Total Assets 166.32
Total Liabilities 166.32
Total Equity 149.14
Share Outstanding 1
Price to Book Ratio 6.69
Return on Assets (%) 34.85
Return on Capital (%) 38.87
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 12.34
Total Assets 122.50
Total Liabilities 122.50
Total Equity 103.32
Share Outstanding 1
Price to Book Ratio 5.73
Return on Assets (%) 35.61
Return on Capital (%) 42.22
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 27.63
Total Assets 88.26
Total Liabilities 88.26
Total Equity 69.94
Share Outstanding 1
Price to Book Ratio 4.23
Return on Assets (%) 34.19
Return on Capital (%) 41.36
Particulars MAR 2025 (Values in Cr)
Net Income 65.53
Cash from Operations 107.51
Cash from Investing -111.81
Cash from Financing 26.01
Net change in Cash 5.22
Free Cash Flow 223.66
Particulars MAR 2024 (Values in Cr)
Net Income 79.33
Cash from Operations 83.99
Cash from Investing -55.21
Cash from Financing -8.58
Net change in Cash 0.41
Free Cash Flow 158.63
Particulars MAR 2023 (Values in Cr)
Net Income 77.46
Cash from Operations 59.89
Cash from Investing -20.40
Cash from Financing -13.27
Net change in Cash 5.79
Free Cash Flow 83.60
Particulars MAR 2022 (Values in Cr)
Net Income 59.03
Cash from Operations 54.82
Cash from Investing -29.83
Cash from Financing -13.99
Net change in Cash -3.51
Free Cash Flow 68.72
Particulars MAR 2021 (Values in Cr)
Net Income 40.88
Cash from Operations 20.65
Cash from Investing -2.25
Cash from Financing -5.16
Net change in Cash 3.11
Free Cash Flow 23.71
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 34.47 14.24 1.66 264.15 23.12 38.85
BLISS GVS PHARMA LTD. 438.05 35.44 3.88 4634.09 118.35 462.70
CIPLA LTD. 1400.70 29.73 3.28 113154.89 1165.55 1672.20
FERMENTA BIOTECH LIMITED 336.90 14.86 2.43 991.53 256.40 399.00
GLAXOSMITHKLINE PHARMACEUTICAL 2166.30 35.95 16.18 36698.43 2155.00 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 34.47 24.10 4.44 264.15 23.12 38.85
AMRUTANJAN HEALTH CARE LTD. 551.70 24.73 4.30 1595.00 490.00 789.95
ASTRAZENECA PHARMA IND LT 8598.60 112.30 24.62 21496.50 7630.00 10653.05
BLISS GVS PHARMA LTD. 438.05 47.10 4.01 4634.09 118.35 462.70

GUJARAT THEMIS BIOSYN LTD shareholding pattern

Holding
26.16%
70.86%
1.79%
1.17%
5.44%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

GUJARAT THEMIS BIOSYN LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
413.20 0.37 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 406.00
  • 26 Days 378.00
  • 10 Days 398.10
  • 50 Days 359.00
  • 12 Days 395.30
  • 100 Days 351.20
  • 20 Days 385.00
  • 200 Days 336.20
414.25 PIVOT
First Support 397.50 First Resistance 428.40 Second Support 383.35 Second Resistance 445.15 Third Support 366.60 Third Resistance 459.30
RSI 60.99 ADX 23.50 MACD 17.27 Williams % R -26.85 Commodity Channel Index (CCI) 100.40
Date 2026-06-05 Week 82756.00 Same Day 61145.00 Month 94304.00
1 Year 1.89 3 Year -4.42
Over 1 Month
7.95% down
Over 1 Year
25.11% down
Over 3 Months
37.36% down
Over 3 Years
0.00% down
Over 6 Months
9.50% down
Over 5 Years
0.00% down

GUJARAT THEMIS BIOSYN LTD Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
04 Sep 2025 0.67 Final 05 Sep 2025 Equity shares
15 Jul 2024 0.25 Final 16 Jul 2024 Equity shares
22 Feb 2024 0.75 Interim 22 Feb 2024 Equity shares
01 Sep 2023 1.0 Final 02 Sep 2023 Equity shares
01 Dec 2022 4.4 Interim 02 Dec 2022 Equity shares
29 Aug 2022 4.0 Final 31 Aug 2022 Equity shares
24 Nov 2021 5.0 Special 25 Nov 2021 Equity shares
24 Nov 2021 2.0 Interim 25 Nov 2021 Equity shares
10 Sep 2020 1.65 Final 14 Sep 2020 Equity shares
Ex-Date Ex-Bonus Ratio
09 Aug 2024 09 Aug 2024 1:2
Ex-Date Old FV NEW FV Record Date
10 Oct 2023 5.0 1.0 10 Oct 2023
Dividend date Dividend amount Dividend type Record date Instrument type
04 Sep 2025 0.67 Final 05 Sep 2025 Equity shares
15 Jul 2024 0.25 Final 16 Jul 2024 Equity shares
22 Feb 2024 0.75 Interim 22 Feb 2024 Equity shares
01 Sep 2023 1.0 Final 02 Sep 2023 Equity shares
01 Dec 2022 4.4 Interim 02 Dec 2022 Equity shares
29 Aug 2022 4.0 Final 31 Aug 2022 Equity shares
24 Nov 2021 5.0 Special 25 Nov 2021 Equity shares
24 Nov 2021 2.0 Interim 25 Nov 2021 Equity shares
10 Sep 2020 1.65 Final 14 Sep 2020 Equity shares
Ex-Date Ex-Bonus Ratio
09 Aug 2024 09 Aug 2024 1:2
Ex-Date Old FV NEW FV Record Date
10 Oct 2023 5.0 1.0 10 Oct 2023

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Gujarat Themis Biosyn Ltd?

Answer Field

Gujarat Themis Biosyn Ltd share price is for NSE ₹ 413.20 & for BSE ₹ 411.85 as on Jun 05 2026 03:30 PM.

What is the Market Cap of Gujarat Themis Biosyn Ltd Share?

Answer Field

The market cap of Gujarat Themis Biosyn Ltd for NSE ₹ 4,502.40 & for BSE ₹ 0.00 as on Jun 05 2026 03:30 PM.

What is the 52 Week High and Low of Gujarat Themis Biosyn Ltd?

Answer Field

The 52 Week High and Low of Gujarat Themis Biosyn Ltd for NSE is ₹ 479.00 and ₹ 225.05 and for BSE is ₹ 479.45 and ₹ 225.75.

What is 1 year return for Gujarat Themis Biosyn Ltd?

Answer Field

The 1 year returns on the stock has been 25.11%.

What is the P/E Ratio of Gujarat Themis Biosyn Ltd Share?

Answer Field

As on Jun 05 2026 03:30 PM the price-to-earnings (PE) ratio for Gujarat Themis Biosyn Ltd share is 96.60.

What is the PB ratio of Gujarat Themis Biosyn Ltd Share?

Answer Field

As on Jun 05 2026 03:30 PM, the price-to-book (PB) ratio for Gujarat Themis Biosyn Ltd share is 26.40.

How to Buy Gujarat Themis Biosyn Ltd Share?

Answer Field

You can trade in Gujarat Themis Biosyn Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Gujarat Themis Biosyn Ltd Share on Bajaj Broking App?

Answer Field

To buy Gujarat Themis Biosyn Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Gujarat Themis Biosyn Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|